nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—Captopril—systemic scleroderma	0.305	0.752	CrCtD
Enalapril—ACE—systemic scleroderma	0.139	1	CbGaD
Enalapril—Lisinopril—systemic scleroderma	0.101	0.248	CrCtD
Enalapril—ACE—Lisinopril—systemic scleroderma	0.0526	0.287	CbGbCtD
Enalapril—ACE—Captopril—systemic scleroderma	0.0394	0.215	CbGbCtD
Enalapril—Fosinopril—Lisinopril—systemic scleroderma	0.0325	0.158	CrCrCtD
Enalapril—Moexipril—Lisinopril—systemic scleroderma	0.0244	0.119	CrCrCtD
Enalapril—SLC15A1—Lisinopril—systemic scleroderma	0.0211	0.115	CbGbCtD
Enalapril—Cilazapril—Lisinopril—systemic scleroderma	0.0211	0.103	CrCrCtD
Enalapril—Spirapril—Lisinopril—systemic scleroderma	0.0211	0.103	CrCrCtD
Enalapril—Trandolapril—Lisinopril—systemic scleroderma	0.0198	0.0962	CrCrCtD
Enalapril—Ramipril—Lisinopril—systemic scleroderma	0.0198	0.0962	CrCrCtD
Enalapril—Nateglinide—Lisinopril—systemic scleroderma	0.0176	0.0858	CrCrCtD
Enalapril—Quinapril—Lisinopril—systemic scleroderma	0.0168	0.0814	CrCrCtD
Enalapril—Aspartame—Lisinopril—systemic scleroderma	0.0168	0.0814	CrCrCtD
Enalapril—Benazepril—Lisinopril—systemic scleroderma	0.016	0.0776	CrCrCtD
Enalapril—SLC15A1—Captopril—systemic scleroderma	0.0158	0.0861	CbGbCtD
Enalapril—SLCO1A2—Prednisone—systemic scleroderma	0.00903	0.0492	CbGbCtD
Enalapril—SLC22A6—Captopril—systemic scleroderma	0.0087	0.0475	CbGbCtD
Enalapril—SLC22A7—Methotrexate—systemic scleroderma	0.00646	0.0352	CbGbCtD
Enalapril—ABCB1—Lisinopril—systemic scleroderma	0.00518	0.0282	CbGbCtD
Enalapril—SLCO1A2—Methotrexate—systemic scleroderma	0.00453	0.0247	CbGbCtD
Enalapril—SLC22A8—Methotrexate—systemic scleroderma	0.00395	0.0215	CbGbCtD
Enalapril—ABCB1—Captopril—systemic scleroderma	0.00388	0.0211	CbGbCtD
Enalapril—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00305	0.0166	CbGbCtD
Enalapril—SLC22A6—Methotrexate—systemic scleroderma	0.00275	0.015	CbGbCtD
Enalapril—ABCB1—Prednisone—systemic scleroderma	0.00244	0.0133	CbGbCtD
Enalapril—ACE—forelimb zeugopod—systemic scleroderma	0.00234	0.219	CbGeAlD
Enalapril—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00997	CbGbCtD
Enalapril—ACE—pulmonary artery—systemic scleroderma	0.00175	0.164	CbGeAlD
Enalapril—ACE—skeletal joint—systemic scleroderma	0.00155	0.145	CbGeAlD
Enalapril—CYP3A4—Prednisone—systemic scleroderma	0.00146	0.00797	CbGbCtD
Enalapril—ABCB1—Methotrexate—systemic scleroderma	0.00122	0.00668	CbGbCtD
Enalapril—ACE—umbilical vein—systemic scleroderma	0.00116	0.108	CbGeAlD
Enalapril—ACE—artery—systemic scleroderma	0.00065	0.0608	CbGeAlD
Enalapril—ACE—endothelium—systemic scleroderma	0.000549	0.0513	CbGeAlD
Enalapril—ACE—blood vessel—systemic scleroderma	0.000506	0.0473	CbGeAlD
Enalapril—Captopril—MMP2—systemic scleroderma	0.000431	0.212	CrCbGaD
Enalapril—SLC22A7—digestive system—systemic scleroderma	0.000325	0.0304	CbGeAlD
Enalapril—Captopril—MMP9—systemic scleroderma	0.000284	0.14	CrCbGaD
Enalapril—SLC15A1—digestive system—systemic scleroderma	0.000261	0.0245	CbGeAlD
Enalapril—ACE—connective tissue—systemic scleroderma	0.000259	0.0243	CbGeAlD
Enalapril—ACE—smooth muscle tissue—systemic scleroderma	0.000237	0.0222	CbGeAlD
Enalapril—SLCO1A2—digestive system—systemic scleroderma	0.000197	0.0184	CbGeAlD
Enalapril—Captopril—ACE—systemic scleroderma	0.000193	0.0948	CrCbGaD
Enalapril—ACE—digestive system—systemic scleroderma	0.000187	0.0175	CbGeAlD
Enalapril—ABCB1—blood vessel—systemic scleroderma	0.000178	0.0167	CbGeAlD
Enalapril—SLCO1A2—lung—systemic scleroderma	0.000164	0.0154	CbGeAlD
Enalapril—ACE—lung—systemic scleroderma	0.000157	0.0146	CbGeAlD
Enalapril—Fosinopril—ACE—systemic scleroderma	0.000149	0.0732	CrCbGaD
Enalapril—Perindopril—ACE—systemic scleroderma	0.000121	0.0596	CrCbGaD
Enalapril—Spirapril—ACE—systemic scleroderma	0.00012	0.059	CrCbGaD
Enalapril—Moexipril—ACE—systemic scleroderma	0.000115	0.0565	CrCbGaD
Enalapril—Quinapril—ACE—systemic scleroderma	0.000107	0.0526	CrCbGaD
Enalapril—Lisinopril—ACE—systemic scleroderma	0.000107	0.0526	CrCbGaD
Enalapril—Cilazapril—ACE—systemic scleroderma	0.000107	0.0526	CrCbGaD
Enalapril—Ramipril—ACE—systemic scleroderma	0.000103	0.0509	CrCbGaD
Enalapril—Trandolapril—ACE—systemic scleroderma	0.000103	0.0509	CrCbGaD
Enalapril—CYP3A4—digestive system—systemic scleroderma	9.32e-05	0.00872	CbGeAlD
Enalapril—Benazepril—ACE—systemic scleroderma	9.29e-05	0.0457	CrCbGaD
Enalapril—ABCB1—digestive system—systemic scleroderma	6.6e-05	0.00617	CbGeAlD
Enalapril—ABCB1—lung—systemic scleroderma	5.51e-05	0.00515	CbGeAlD
Enalapril—Anaphylactic shock—Lisinopril—systemic scleroderma	3.1e-05	0.000583	CcSEcCtD
Enalapril—Oedema—Lisinopril—systemic scleroderma	3.1e-05	0.000583	CcSEcCtD
Enalapril—Pruritus—Captopril—systemic scleroderma	3.09e-05	0.000582	CcSEcCtD
Enalapril—Paraesthesia—Mycophenolic acid—systemic scleroderma	3.09e-05	0.000581	CcSEcCtD
Enalapril—Constipation—Leflunomide—systemic scleroderma	3.08e-05	0.00058	CcSEcCtD
Enalapril—Anaemia—Mycophenolate mofetil—systemic scleroderma	3.07e-05	0.000578	CcSEcCtD
Enalapril—Dyspnoea—Mycophenolic acid—systemic scleroderma	3.07e-05	0.000577	CcSEcCtD
Enalapril—Somnolence—Mycophenolic acid—systemic scleroderma	3.06e-05	0.000575	CcSEcCtD
Enalapril—Agitation—Mycophenolate mofetil—systemic scleroderma	3.06e-05	0.000575	CcSEcCtD
Enalapril—Shock—Lisinopril—systemic scleroderma	3.05e-05	0.000573	CcSEcCtD
Enalapril—Angioedema—Mycophenolate mofetil—systemic scleroderma	3.04e-05	0.000572	CcSEcCtD
Enalapril—Thrombocytopenia—Lisinopril—systemic scleroderma	3.03e-05	0.00057	CcSEcCtD
Enalapril—Dyspepsia—Mycophenolic acid—systemic scleroderma	3.03e-05	0.000569	CcSEcCtD
Enalapril—Neutropenia—Prednisone—systemic scleroderma	3.02e-05	0.000569	CcSEcCtD
Enalapril—Tachycardia—Lisinopril—systemic scleroderma	3.02e-05	0.000569	CcSEcCtD
Enalapril—Body temperature increased—Azathioprine—systemic scleroderma	3.02e-05	0.000568	CcSEcCtD
Enalapril—Abdominal pain—Azathioprine—systemic scleroderma	3.02e-05	0.000568	CcSEcCtD
Enalapril—Hyperhidrosis—Lisinopril—systemic scleroderma	2.99e-05	0.000563	CcSEcCtD
Enalapril—Diarrhoea—Captopril—systemic scleroderma	2.99e-05	0.000563	CcSEcCtD
Enalapril—Decreased appetite—Mycophenolic acid—systemic scleroderma	2.99e-05	0.000562	CcSEcCtD
Enalapril—Vertigo—Mycophenolate mofetil—systemic scleroderma	2.99e-05	0.000562	CcSEcCtD
Enalapril—Irritability—Methotrexate—systemic scleroderma	2.98e-05	0.000562	CcSEcCtD
Enalapril—Syncope—Mycophenolate mofetil—systemic scleroderma	2.98e-05	0.000561	CcSEcCtD
Enalapril—Erectile dysfunction—Prednisone—systemic scleroderma	2.98e-05	0.00056	CcSEcCtD
Enalapril—Leukopenia—Mycophenolate mofetil—systemic scleroderma	2.98e-05	0.00056	CcSEcCtD
Enalapril—Feeling abnormal—Leflunomide—systemic scleroderma	2.97e-05	0.000559	CcSEcCtD
Enalapril—Fatigue—Mycophenolic acid—systemic scleroderma	2.96e-05	0.000558	CcSEcCtD
Enalapril—Nausea—Mometasone—systemic scleroderma	2.96e-05	0.000556	CcSEcCtD
Enalapril—Anorexia—Lisinopril—systemic scleroderma	2.95e-05	0.000555	CcSEcCtD
Enalapril—Gastrointestinal pain—Leflunomide—systemic scleroderma	2.95e-05	0.000554	CcSEcCtD
Enalapril—Ataxia—Methotrexate—systemic scleroderma	2.94e-05	0.000553	CcSEcCtD
Enalapril—Constipation—Mycophenolic acid—systemic scleroderma	2.94e-05	0.000553	CcSEcCtD
Enalapril—Palpitations—Mycophenolate mofetil—systemic scleroderma	2.94e-05	0.000553	CcSEcCtD
Enalapril—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	2.92e-05	0.00055	CcSEcCtD
Enalapril—Hyperglycaemia—Prednisone—systemic scleroderma	2.92e-05	0.000549	CcSEcCtD
Enalapril—Cough—Mycophenolate mofetil—systemic scleroderma	2.9e-05	0.000546	CcSEcCtD
Enalapril—Hypotension—Lisinopril—systemic scleroderma	2.89e-05	0.000544	CcSEcCtD
Enalapril—Dizziness—Captopril—systemic scleroderma	2.89e-05	0.000544	CcSEcCtD
Enalapril—Depression—Prednisone—systemic scleroderma	2.88e-05	0.000541	CcSEcCtD
Enalapril—Urticaria—Leflunomide—systemic scleroderma	2.86e-05	0.000539	CcSEcCtD
Enalapril—Body temperature increased—Leflunomide—systemic scleroderma	2.85e-05	0.000536	CcSEcCtD
Enalapril—Abdominal pain—Leflunomide—systemic scleroderma	2.85e-05	0.000536	CcSEcCtD
Enalapril—Acute coronary syndrome—Prednisone—systemic scleroderma	2.84e-05	0.000535	CcSEcCtD
Enalapril—Feeling abnormal—Mycophenolic acid—systemic scleroderma	2.83e-05	0.000533	CcSEcCtD
Enalapril—Arthralgia—Mycophenolate mofetil—systemic scleroderma	2.83e-05	0.000533	CcSEcCtD
Enalapril—Chest pain—Mycophenolate mofetil—systemic scleroderma	2.83e-05	0.000533	CcSEcCtD
Enalapril—Myalgia—Mycophenolate mofetil—systemic scleroderma	2.83e-05	0.000533	CcSEcCtD
Enalapril—Myocardial infarction—Prednisone—systemic scleroderma	2.83e-05	0.000532	CcSEcCtD
Enalapril—Neuropathy peripheral—Prednisone—systemic scleroderma	2.83e-05	0.000532	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	2.82e-05	0.000531	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	2.82e-05	0.00053	CcSEcCtD
Enalapril—Hypersensitivity—Azathioprine—systemic scleroderma	2.81e-05	0.000529	CcSEcCtD
Enalapril—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	2.81e-05	0.000529	CcSEcCtD
Enalapril—Insomnia—Lisinopril—systemic scleroderma	2.8e-05	0.000527	CcSEcCtD
Enalapril—Discomfort—Mycophenolate mofetil—systemic scleroderma	2.8e-05	0.000526	CcSEcCtD
Enalapril—Paraesthesia—Lisinopril—systemic scleroderma	2.78e-05	0.000523	CcSEcCtD
Enalapril—Vomiting—Captopril—systemic scleroderma	2.78e-05	0.000523	CcSEcCtD
Enalapril—Dry mouth—Mycophenolate mofetil—systemic scleroderma	2.77e-05	0.000521	CcSEcCtD
Enalapril—Dyspnoea—Lisinopril—systemic scleroderma	2.76e-05	0.000519	CcSEcCtD
Enalapril—Rash—Captopril—systemic scleroderma	2.76e-05	0.000519	CcSEcCtD
Enalapril—Dermatitis—Captopril—systemic scleroderma	2.75e-05	0.000518	CcSEcCtD
Enalapril—Somnolence—Lisinopril—systemic scleroderma	2.75e-05	0.000518	CcSEcCtD
Enalapril—Headache—Captopril—systemic scleroderma	2.74e-05	0.000515	CcSEcCtD
Enalapril—Confusional state—Mycophenolate mofetil—systemic scleroderma	2.74e-05	0.000515	CcSEcCtD
Enalapril—Dyspepsia—Lisinopril—systemic scleroderma	2.73e-05	0.000513	CcSEcCtD
Enalapril—Abdominal pain—Mycophenolic acid—systemic scleroderma	2.72e-05	0.000511	CcSEcCtD
Enalapril—Body temperature increased—Mycophenolic acid—systemic scleroderma	2.72e-05	0.000511	CcSEcCtD
Enalapril—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	2.71e-05	0.000511	CcSEcCtD
Enalapril—Oedema—Mycophenolate mofetil—systemic scleroderma	2.71e-05	0.000511	CcSEcCtD
Enalapril—Asthma—Methotrexate—systemic scleroderma	2.7e-05	0.000509	CcSEcCtD
Enalapril—Decreased appetite—Lisinopril—systemic scleroderma	2.69e-05	0.000506	CcSEcCtD
Enalapril—Eosinophilia—Methotrexate—systemic scleroderma	2.68e-05	0.000504	CcSEcCtD
Enalapril—Fatigue—Lisinopril—systemic scleroderma	2.67e-05	0.000502	CcSEcCtD
Enalapril—Shock—Mycophenolate mofetil—systemic scleroderma	2.67e-05	0.000502	CcSEcCtD
Enalapril—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	2.66e-05	0.0005	CcSEcCtD
Enalapril—Hypersensitivity—Leflunomide—systemic scleroderma	2.66e-05	0.0005	CcSEcCtD
Enalapril—Pancreatitis—Methotrexate—systemic scleroderma	2.65e-05	0.000499	CcSEcCtD
Enalapril—Constipation—Lisinopril—systemic scleroderma	2.65e-05	0.000498	CcSEcCtD
Enalapril—Tachycardia—Mycophenolate mofetil—systemic scleroderma	2.65e-05	0.000498	CcSEcCtD
Enalapril—Bradycardia—Prednisone—systemic scleroderma	2.64e-05	0.000496	CcSEcCtD
Enalapril—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	2.62e-05	0.000494	CcSEcCtD
Enalapril—Diarrhoea—Azathioprine—systemic scleroderma	2.61e-05	0.000491	CcSEcCtD
Enalapril—Nausea—Captopril—systemic scleroderma	2.6e-05	0.000489	CcSEcCtD
Enalapril—Anorexia—Mycophenolate mofetil—systemic scleroderma	2.59e-05	0.000487	CcSEcCtD
Enalapril—Asthenia—Leflunomide—systemic scleroderma	2.59e-05	0.000487	CcSEcCtD
Enalapril—Pancytopenia—Methotrexate—systemic scleroderma	2.57e-05	0.000483	CcSEcCtD
Enalapril—Feeling abnormal—Lisinopril—systemic scleroderma	2.55e-05	0.00048	CcSEcCtD
Enalapril—Pruritus—Leflunomide—systemic scleroderma	2.55e-05	0.00048	CcSEcCtD
Enalapril—Hypotension—Mycophenolate mofetil—systemic scleroderma	2.54e-05	0.000477	CcSEcCtD
Enalapril—Gastrointestinal pain—Lisinopril—systemic scleroderma	2.53e-05	0.000476	CcSEcCtD
Enalapril—Neutropenia—Methotrexate—systemic scleroderma	2.53e-05	0.000476	CcSEcCtD
Enalapril—Dysuria—Methotrexate—systemic scleroderma	2.53e-05	0.000476	CcSEcCtD
Enalapril—Dizziness—Azathioprine—systemic scleroderma	2.52e-05	0.000475	CcSEcCtD
Enalapril—Upper respiratory tract infection—Methotrexate—systemic scleroderma	2.51e-05	0.000473	CcSEcCtD
Enalapril—Erectile dysfunction—Methotrexate—systemic scleroderma	2.49e-05	0.000468	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	2.47e-05	0.000465	CcSEcCtD
Enalapril—Photosensitivity reaction—Methotrexate—systemic scleroderma	2.47e-05	0.000464	CcSEcCtD
Enalapril—Asthenia—Mycophenolic acid—systemic scleroderma	2.47e-05	0.000464	CcSEcCtD
Enalapril—Diarrhoea—Leflunomide—systemic scleroderma	2.47e-05	0.000464	CcSEcCtD
Enalapril—Urticaria—Lisinopril—systemic scleroderma	2.46e-05	0.000463	CcSEcCtD
Enalapril—Insomnia—Mycophenolate mofetil—systemic scleroderma	2.45e-05	0.000462	CcSEcCtD
Enalapril—Abdominal pain—Lisinopril—systemic scleroderma	2.45e-05	0.000461	CcSEcCtD
Enalapril—Body temperature increased—Lisinopril—systemic scleroderma	2.45e-05	0.000461	CcSEcCtD
Enalapril—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	2.44e-05	0.000458	CcSEcCtD
Enalapril—Pruritus—Mycophenolic acid—systemic scleroderma	2.43e-05	0.000458	CcSEcCtD
Enalapril—Vomiting—Azathioprine—systemic scleroderma	2.43e-05	0.000457	CcSEcCtD
Enalapril—Pneumonia—Methotrexate—systemic scleroderma	2.42e-05	0.000456	CcSEcCtD
Enalapril—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	2.42e-05	0.000455	CcSEcCtD
Enalapril—Somnolence—Mycophenolate mofetil—systemic scleroderma	2.41e-05	0.000454	CcSEcCtD
Enalapril—Rash—Azathioprine—systemic scleroderma	2.41e-05	0.000453	CcSEcCtD
Enalapril—Dermatitis—Azathioprine—systemic scleroderma	2.4e-05	0.000452	CcSEcCtD
Enalapril—Depression—Methotrexate—systemic scleroderma	2.4e-05	0.000452	CcSEcCtD
Enalapril—Flushing—Prednisone—systemic scleroderma	2.4e-05	0.000452	CcSEcCtD
Enalapril—Headache—Azathioprine—systemic scleroderma	2.39e-05	0.00045	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	2.39e-05	0.00045	CcSEcCtD
Enalapril—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	2.39e-05	0.000449	CcSEcCtD
Enalapril—Dizziness—Leflunomide—systemic scleroderma	2.38e-05	0.000448	CcSEcCtD
Enalapril—Renal failure—Methotrexate—systemic scleroderma	2.37e-05	0.000446	CcSEcCtD
Enalapril—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	2.36e-05	0.000444	CcSEcCtD
Enalapril—Diarrhoea—Mycophenolic acid—systemic scleroderma	2.35e-05	0.000443	CcSEcCtD
Enalapril—Stomatitis—Methotrexate—systemic scleroderma	2.35e-05	0.000442	CcSEcCtD
Enalapril—Conjunctivitis—Methotrexate—systemic scleroderma	2.34e-05	0.000441	CcSEcCtD
Enalapril—Constipation—Mycophenolate mofetil—systemic scleroderma	2.32e-05	0.000437	CcSEcCtD
Enalapril—Arrhythmia—Prednisone—systemic scleroderma	2.31e-05	0.000435	CcSEcCtD
Enalapril—Vomiting—Leflunomide—systemic scleroderma	2.29e-05	0.000431	CcSEcCtD
Enalapril—Alopecia—Prednisone—systemic scleroderma	2.29e-05	0.00043	CcSEcCtD
Enalapril—Hypersensitivity—Lisinopril—systemic scleroderma	2.28e-05	0.000429	CcSEcCtD
Enalapril—Dizziness—Mycophenolic acid—systemic scleroderma	2.27e-05	0.000428	CcSEcCtD
Enalapril—Epistaxis—Methotrexate—systemic scleroderma	2.27e-05	0.000428	CcSEcCtD
Enalapril—Rash—Leflunomide—systemic scleroderma	2.27e-05	0.000428	CcSEcCtD
Enalapril—Dermatitis—Leflunomide—systemic scleroderma	2.27e-05	0.000427	CcSEcCtD
Enalapril—Nausea—Azathioprine—systemic scleroderma	2.27e-05	0.000427	CcSEcCtD
Enalapril—Headache—Leflunomide—systemic scleroderma	2.26e-05	0.000425	CcSEcCtD
Enalapril—Erythema—Prednisone—systemic scleroderma	2.25e-05	0.000424	CcSEcCtD
Enalapril—Agranulocytosis—Methotrexate—systemic scleroderma	2.25e-05	0.000423	CcSEcCtD
Enalapril—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	2.24e-05	0.000421	CcSEcCtD
Enalapril—Asthenia—Lisinopril—systemic scleroderma	2.22e-05	0.000418	CcSEcCtD
Enalapril—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	2.22e-05	0.000417	CcSEcCtD
Enalapril—Pruritus—Lisinopril—systemic scleroderma	2.19e-05	0.000412	CcSEcCtD
Enalapril—Vomiting—Mycophenolic acid—systemic scleroderma	2.19e-05	0.000411	CcSEcCtD
Enalapril—Rash—Mycophenolic acid—systemic scleroderma	2.17e-05	0.000408	CcSEcCtD
Enalapril—Dermatitis—Mycophenolic acid—systemic scleroderma	2.17e-05	0.000407	CcSEcCtD
Enalapril—Hepatitis—Methotrexate—systemic scleroderma	2.16e-05	0.000407	CcSEcCtD
Enalapril—Urticaria—Mycophenolate mofetil—systemic scleroderma	2.16e-05	0.000406	CcSEcCtD
Enalapril—Headache—Mycophenolic acid—systemic scleroderma	2.15e-05	0.000405	CcSEcCtD
Enalapril—Pharyngitis—Methotrexate—systemic scleroderma	2.15e-05	0.000404	CcSEcCtD
Enalapril—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	2.14e-05	0.000404	CcSEcCtD
Enalapril—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	2.14e-05	0.000404	CcSEcCtD
Enalapril—Nausea—Leflunomide—systemic scleroderma	2.14e-05	0.000403	CcSEcCtD
Enalapril—Vision blurred—Prednisone—systemic scleroderma	2.12e-05	0.0004	CcSEcCtD
Enalapril—Diarrhoea—Lisinopril—systemic scleroderma	2.12e-05	0.000399	CcSEcCtD
Enalapril—Visual impairment—Methotrexate—systemic scleroderma	2.08e-05	0.000392	CcSEcCtD
Enalapril—Anaemia—Prednisone—systemic scleroderma	2.08e-05	0.000392	CcSEcCtD
Enalapril—Agitation—Prednisone—systemic scleroderma	2.07e-05	0.00039	CcSEcCtD
Enalapril—Angioedema—Prednisone—systemic scleroderma	2.06e-05	0.000387	CcSEcCtD
Enalapril—Dizziness—Lisinopril—systemic scleroderma	2.05e-05	0.000385	CcSEcCtD
Enalapril—Erythema multiforme—Methotrexate—systemic scleroderma	2.05e-05	0.000385	CcSEcCtD
Enalapril—Nausea—Mycophenolic acid—systemic scleroderma	2.04e-05	0.000384	CcSEcCtD
Enalapril—Vertigo—Prednisone—systemic scleroderma	2.02e-05	0.000381	CcSEcCtD
Enalapril—Syncope—Prednisone—systemic scleroderma	2.02e-05	0.00038	CcSEcCtD
Enalapril—Tinnitus—Methotrexate—systemic scleroderma	2.02e-05	0.00038	CcSEcCtD
Enalapril—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	2e-05	0.000376	CcSEcCtD
Enalapril—Loss of consciousness—Prednisone—systemic scleroderma	1.98e-05	0.000373	CcSEcCtD
Enalapril—Vomiting—Lisinopril—systemic scleroderma	1.97e-05	0.00037	CcSEcCtD
Enalapril—Rash—Lisinopril—systemic scleroderma	1.95e-05	0.000367	CcSEcCtD
Enalapril—Dermatitis—Lisinopril—systemic scleroderma	1.95e-05	0.000367	CcSEcCtD
Enalapril—Asthenia—Mycophenolate mofetil—systemic scleroderma	1.95e-05	0.000366	CcSEcCtD
Enalapril—Headache—Lisinopril—systemic scleroderma	1.94e-05	0.000365	CcSEcCtD
Enalapril—Pruritus—Mycophenolate mofetil—systemic scleroderma	1.92e-05	0.000361	CcSEcCtD
Enalapril—Arthralgia—Prednisone—systemic scleroderma	1.92e-05	0.000361	CcSEcCtD
Enalapril—Myalgia—Prednisone—systemic scleroderma	1.92e-05	0.000361	CcSEcCtD
Enalapril—Alopecia—Methotrexate—systemic scleroderma	1.91e-05	0.00036	CcSEcCtD
Enalapril—Discomfort—Prednisone—systemic scleroderma	1.9e-05	0.000357	CcSEcCtD
Enalapril—Erythema—Methotrexate—systemic scleroderma	1.88e-05	0.000354	CcSEcCtD
Enalapril—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	1.86e-05	0.000349	CcSEcCtD
Enalapril—Dysgeusia—Methotrexate—systemic scleroderma	1.84e-05	0.000347	CcSEcCtD
Enalapril—Nausea—Lisinopril—systemic scleroderma	1.84e-05	0.000346	CcSEcCtD
Enalapril—Anaphylactic shock—Prednisone—systemic scleroderma	1.84e-05	0.000346	CcSEcCtD
Enalapril—Oedema—Prednisone—systemic scleroderma	1.84e-05	0.000346	CcSEcCtD
Enalapril—Back pain—Methotrexate—systemic scleroderma	1.82e-05	0.000343	CcSEcCtD
Enalapril—Shock—Prednisone—systemic scleroderma	1.81e-05	0.00034	CcSEcCtD
Enalapril—Tachycardia—Prednisone—systemic scleroderma	1.79e-05	0.000338	CcSEcCtD
Enalapril—Dizziness—Mycophenolate mofetil—systemic scleroderma	1.79e-05	0.000338	CcSEcCtD
Enalapril—Hyperhidrosis—Prednisone—systemic scleroderma	1.78e-05	0.000335	CcSEcCtD
Enalapril—Vision blurred—Methotrexate—systemic scleroderma	1.77e-05	0.000334	CcSEcCtD
Enalapril—Anorexia—Prednisone—systemic scleroderma	1.75e-05	0.00033	CcSEcCtD
Enalapril—Anaemia—Methotrexate—systemic scleroderma	1.74e-05	0.000328	CcSEcCtD
Enalapril—Vomiting—Mycophenolate mofetil—systemic scleroderma	1.73e-05	0.000325	CcSEcCtD
Enalapril—Rash—Mycophenolate mofetil—systemic scleroderma	1.71e-05	0.000322	CcSEcCtD
Enalapril—Dermatitis—Mycophenolate mofetil—systemic scleroderma	1.71e-05	0.000322	CcSEcCtD
Enalapril—Headache—Mycophenolate mofetil—systemic scleroderma	1.7e-05	0.00032	CcSEcCtD
Enalapril—Vertigo—Methotrexate—systemic scleroderma	1.69e-05	0.000318	CcSEcCtD
Enalapril—Leukopenia—Methotrexate—systemic scleroderma	1.69e-05	0.000317	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Prednisone—systemic scleroderma	1.68e-05	0.000315	CcSEcCtD
Enalapril—Insomnia—Prednisone—systemic scleroderma	1.66e-05	0.000313	CcSEcCtD
Enalapril—Paraesthesia—Prednisone—systemic scleroderma	1.65e-05	0.000311	CcSEcCtD
Enalapril—Cough—Methotrexate—systemic scleroderma	1.64e-05	0.000309	CcSEcCtD
Enalapril—Dyspepsia—Prednisone—systemic scleroderma	1.62e-05	0.000305	CcSEcCtD
Enalapril—Nausea—Mycophenolate mofetil—systemic scleroderma	1.61e-05	0.000303	CcSEcCtD
Enalapril—Myalgia—Methotrexate—systemic scleroderma	1.6e-05	0.000302	CcSEcCtD
Enalapril—Arthralgia—Methotrexate—systemic scleroderma	1.6e-05	0.000302	CcSEcCtD
Enalapril—Chest pain—Methotrexate—systemic scleroderma	1.6e-05	0.000302	CcSEcCtD
Enalapril—Decreased appetite—Prednisone—systemic scleroderma	1.6e-05	0.000301	CcSEcCtD
Enalapril—Fatigue—Prednisone—systemic scleroderma	1.59e-05	0.000298	CcSEcCtD
Enalapril—Discomfort—Methotrexate—systemic scleroderma	1.58e-05	0.000298	CcSEcCtD
Enalapril—Constipation—Prednisone—systemic scleroderma	1.57e-05	0.000296	CcSEcCtD
Enalapril—Confusional state—Methotrexate—systemic scleroderma	1.55e-05	0.000292	CcSEcCtD
Enalapril—Anaphylactic shock—Methotrexate—systemic scleroderma	1.54e-05	0.000289	CcSEcCtD
Enalapril—Feeling abnormal—Prednisone—systemic scleroderma	1.52e-05	0.000285	CcSEcCtD
Enalapril—Thrombocytopenia—Methotrexate—systemic scleroderma	1.5e-05	0.000283	CcSEcCtD
Enalapril—Gastrointestinal pain—Prednisone—systemic scleroderma	1.5e-05	0.000283	CcSEcCtD
Enalapril—Hyperhidrosis—Methotrexate—systemic scleroderma	1.49e-05	0.00028	CcSEcCtD
Enalapril—Anorexia—Methotrexate—systemic scleroderma	1.47e-05	0.000276	CcSEcCtD
Enalapril—Urticaria—Prednisone—systemic scleroderma	1.46e-05	0.000275	CcSEcCtD
Enalapril—Abdominal pain—Prednisone—systemic scleroderma	1.45e-05	0.000274	CcSEcCtD
Enalapril—Body temperature increased—Prednisone—systemic scleroderma	1.45e-05	0.000274	CcSEcCtD
Enalapril—Hypotension—Methotrexate—systemic scleroderma	1.44e-05	0.00027	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	1.4e-05	0.000263	CcSEcCtD
Enalapril—Insomnia—Methotrexate—systemic scleroderma	1.39e-05	0.000262	CcSEcCtD
Enalapril—Paraesthesia—Methotrexate—systemic scleroderma	1.38e-05	0.00026	CcSEcCtD
Enalapril—Dyspnoea—Methotrexate—systemic scleroderma	1.37e-05	0.000258	CcSEcCtD
Enalapril—Somnolence—Methotrexate—systemic scleroderma	1.37e-05	0.000257	CcSEcCtD
Enalapril—Hypersensitivity—Prednisone—systemic scleroderma	1.36e-05	0.000255	CcSEcCtD
Enalapril—Dyspepsia—Methotrexate—systemic scleroderma	1.35e-05	0.000255	CcSEcCtD
Enalapril—Decreased appetite—Methotrexate—systemic scleroderma	1.34e-05	0.000251	CcSEcCtD
Enalapril—Fatigue—Methotrexate—systemic scleroderma	1.33e-05	0.000249	CcSEcCtD
Enalapril—Asthenia—Prednisone—systemic scleroderma	1.32e-05	0.000248	CcSEcCtD
Enalapril—Pruritus—Prednisone—systemic scleroderma	1.3e-05	0.000245	CcSEcCtD
Enalapril—Feeling abnormal—Methotrexate—systemic scleroderma	1.27e-05	0.000238	CcSEcCtD
Enalapril—Diarrhoea—Prednisone—systemic scleroderma	1.26e-05	0.000237	CcSEcCtD
Enalapril—Gastrointestinal pain—Methotrexate—systemic scleroderma	1.26e-05	0.000236	CcSEcCtD
Enalapril—Urticaria—Methotrexate—systemic scleroderma	1.22e-05	0.00023	CcSEcCtD
Enalapril—Dizziness—Prednisone—systemic scleroderma	1.22e-05	0.000229	CcSEcCtD
Enalapril—Body temperature increased—Methotrexate—systemic scleroderma	1.22e-05	0.000229	CcSEcCtD
Enalapril—Abdominal pain—Methotrexate—systemic scleroderma	1.22e-05	0.000229	CcSEcCtD
Enalapril—Vomiting—Prednisone—systemic scleroderma	1.17e-05	0.00022	CcSEcCtD
Enalapril—Rash—Prednisone—systemic scleroderma	1.16e-05	0.000218	CcSEcCtD
Enalapril—Dermatitis—Prednisone—systemic scleroderma	1.16e-05	0.000218	CcSEcCtD
Enalapril—Headache—Prednisone—systemic scleroderma	1.15e-05	0.000217	CcSEcCtD
Enalapril—Hypersensitivity—Methotrexate—systemic scleroderma	1.13e-05	0.000213	CcSEcCtD
Enalapril—Asthenia—Methotrexate—systemic scleroderma	1.1e-05	0.000207	CcSEcCtD
Enalapril—Nausea—Prednisone—systemic scleroderma	1.09e-05	0.000206	CcSEcCtD
Enalapril—Pruritus—Methotrexate—systemic scleroderma	1.09e-05	0.000205	CcSEcCtD
Enalapril—Diarrhoea—Methotrexate—systemic scleroderma	1.05e-05	0.000198	CcSEcCtD
Enalapril—Dizziness—Methotrexate—systemic scleroderma	1.02e-05	0.000191	CcSEcCtD
Enalapril—Vomiting—Methotrexate—systemic scleroderma	9.77e-06	0.000184	CcSEcCtD
Enalapril—Rash—Methotrexate—systemic scleroderma	9.69e-06	0.000182	CcSEcCtD
Enalapril—Dermatitis—Methotrexate—systemic scleroderma	9.68e-06	0.000182	CcSEcCtD
Enalapril—Headache—Methotrexate—systemic scleroderma	9.63e-06	0.000181	CcSEcCtD
Enalapril—Nausea—Methotrexate—systemic scleroderma	9.13e-06	0.000172	CcSEcCtD
